These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 29281830)
1. Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis. Yue M; Jiang J; Gao P; Liu H; Qing G Cell Rep; 2017 Dec; 21(13):3819-3832. PubMed ID: 29281830 [TBL] [Abstract][Full Text] [Related]
2. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival. Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673 [TBL] [Abstract][Full Text] [Related]
3. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Hayashi K; Jutabha P; Endou H; Anzai N Oncol Rep; 2012 Sep; 28(3):862-6. PubMed ID: 22736142 [TBL] [Abstract][Full Text] [Related]
4. Menin enhances c-Myc-mediated transcription to promote cancer progression. Wu G; Yuan M; Shen S; Ma X; Fang J; Zhu L; Sun L; Liu Z; He X; Huang D; Li T; Li C; Wu J; Hu X; Li Z; Song L; Qu K; Zhang H; Gao P Nat Commun; 2017 May; 8():15278. PubMed ID: 28474697 [TBL] [Abstract][Full Text] [Related]
5. A MYC-GCN2-eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer. Schmidt S; Gay D; Uthe FW; Denk S; Paauwe M; Matthes N; Diefenbacher ME; Bryson S; Warrander FC; Erhard F; Ade CP; Baluapuri A; Walz S; Jackstadt R; Ford C; Vlachogiannis G; Valeri N; Otto C; Schülein-Völk C; Maurus K; Schmitz W; Knight JRP; Wolf E; Strathdee D; Schulze A; Germer CT; Rosenwald A; Sansom OJ; Eilers M; Wiegering A Nat Cell Biol; 2019 Nov; 21(11):1413-1424. PubMed ID: 31685988 [TBL] [Abstract][Full Text] [Related]
6. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552 [TBL] [Abstract][Full Text] [Related]
7. ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Qing G; Li B; Vu A; Skuli N; Walton ZE; Liu X; Mayes PA; Wise DR; Thompson CB; Maris JM; Hogarty MD; Simon MC Cancer Cell; 2012 Nov; 22(5):631-44. PubMed ID: 23153536 [TBL] [Abstract][Full Text] [Related]
8. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer. Venkateswaran N; Lafita-Navarro MC; Hao YH; Kilgore JA; Perez-Castro L; Braverman J; Borenstein-Auerbach N; Kim M; Lesner NP; Mishra P; Brabletz T; Shay JW; DeBerardinis RJ; Williams NS; Yilmaz OH; Conacci-Sorrell M Genes Dev; 2019 Sep; 33(17-18):1236-1251. PubMed ID: 31416966 [TBL] [Abstract][Full Text] [Related]
9. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line. Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798 [TBL] [Abstract][Full Text] [Related]
10. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028 [TBL] [Abstract][Full Text] [Related]
11. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. Elorza A; Soro-Arnáiz I; Meléndez-Rodríguez F; Rodríguez-Vaello V; Marsboom G; de Cárcer G; Acosta-Iborra B; Albacete-Albacete L; Ordóñez A; Serrano-Oviedo L; Giménez-Bachs JM; Vara-Vega A; Salinas A; Sánchez-Prieto R; Martín del Río R; Sánchez-Madrid F; Malumbres M; Landázuri MO; Aragonés J Mol Cell; 2012 Dec; 48(5):681-91. PubMed ID: 23103253 [TBL] [Abstract][Full Text] [Related]
12. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2. Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916 [TBL] [Abstract][Full Text] [Related]
13. FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis. Li X; Wang W; Xi Y; Gao M; Tran M; Aziz KE; Qin J; Li W; Chen J Cell Rep; 2016 Jul; 16(2):487-497. PubMed ID: 27346356 [TBL] [Abstract][Full Text] [Related]
14. A positive feedback loop between EBP2 and c-Myc regulates rDNA transcription, cell proliferation, and tumorigenesis. Liao P; Wang W; Shen M; Pan W; Zhang K; Wang R; Chen T; Chen Y; Chen H; Wang P Cell Death Dis; 2014 Jan; 5(1):e1032. PubMed ID: 24481446 [TBL] [Abstract][Full Text] [Related]
15. Aurora kinase A mediates c-Myc's oncogenic effects in hepatocellular carcinoma. Lu L; Han H; Tian Y; Li W; Zhang J; Feng M; Li Y Mol Carcinog; 2015 Nov; 54(11):1467-79. PubMed ID: 25284017 [TBL] [Abstract][Full Text] [Related]
16. Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis. Desi N; Tong QY; Teh V; Chan JJ; Zhang B; Tabatabaeian H; Tan HQ; Kapeli K; Jin W; Lim CY; Kwok ZH; Tan HT; Wang S; Siew BE; Lee KC; Chong CS; Tan KK; Yang H; Kappei D; Yeo GW; Chung MCM; Tay Y Cell Mol Life Sci; 2022 Feb; 79(3):147. PubMed ID: 35195778 [TBL] [Abstract][Full Text] [Related]
17. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934 [TBL] [Abstract][Full Text] [Related]
18. MYC phosphorylation at novel regulatory regions suppresses transforming activity. Wasylishen AR; Chan-Seng-Yue M; Bros C; Dingar D; Tu WB; Kalkat M; Chan PK; Mullen PJ; Huang L; Meyer N; Raught B; Boutros PC; Penn LZ Cancer Res; 2013 Nov; 73(21):6504-15. PubMed ID: 24030976 [TBL] [Abstract][Full Text] [Related]
19. [Effect of SLC7A5 on the proliferation of tumor cells and its relationship with transforming growth factor-β1 signal pathway]. Zhao T; Li D; Liu X; Liu Z; Wu D; Zhou S; Duan H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):485-492. PubMed ID: 28626091 [TBL] [Abstract][Full Text] [Related]
20. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy. Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]